Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

309
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
309
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

463
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
463
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

886
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
886
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

299
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
299
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

454
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
454
Censoring Survival Data01:09

Censoring Survival Data

422
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bayesian approach towards the identification of latent subgroups.

Statistical methods in medical research·2025
Same author

Creating a Proxy for Baseline Eastern Cooperative Oncology Group Performance Status in Electronic Health Records for Comparative Effectiveness Research in Advanced Non-Small Cell Lung Cancer.

JCO clinical cancer informatics·2025
Same author

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs.

Bioanalysis·2024
Same author

Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119.

The journal of pathology. Clinical research·2024
Same author

Covariate-adjusted value-guided subgroup identification via boosting.

Journal of biopharmaceutical statistics·2023

Related Experiment Video

Updated: Dec 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K

A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored

Pingye Zhang1, Junshui Ma1, Xinqun Chen1

  • 1Biostatistics and Research Decision Sciences, MRL, Merck & Co., Inc., Rahway, New Jersey, USA.

Statistics in Medicine
|August 14, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for identifying patient subgroups that benefit most from treatments in clinical trials. It uses a value function and gradient tree boosting to optimize treatment assignment for individual patients based on survival outcomes.

Keywords:
censored survival datagradient tree boostingnonparametricpersonalized medicinerestricted mean survival timesubgroup identification

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

448

Related Experiment Videos

Last Updated: Dec 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

448

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Genomics

Background:

  • Identifying patient subgroups in clinical trials is crucial for personalized medicine.
  • Existing methods often focus on treatment assignment rather than optimizing outcomes for individuals.
  • Individualized treatment regimes aim to maximize expected clinical outcomes using value functions.

Purpose of the Study:

  • To propose a novel nonparametric method for subgroup identification in randomized clinical trials.
  • To connect value function concepts with subgroup identification for optimizing treatment effects.
  • To develop a method that directly reflects subgroup-treatment interactions using restricted mean survival time.

Main Methods:

  • A nonparametric approach is proposed to search for subgroup membership scores.
  • The method maximizes a value function reflecting subgroup-treatment interaction effects.
  • A gradient tree boosting algorithm is utilized to determine individual subgroup membership scores.

Main Results:

  • Simulation studies demonstrated the effectiveness of the proposed method.
  • The method successfully identified subgroups with differential treatment benefits.
  • Application to an AIDS clinical trial illustrated its practical utility.

Conclusions:

  • The proposed method offers a powerful tool for subgroup identification in survival outcome trials.
  • It facilitates personalized treatment strategies by optimizing for individual patient outcomes.
  • This approach enhances the precision of treatment effect estimation and clinical decision-making.